Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns almost 50% of revenue in the U.S., 30% in Europe with Asia Pacific the biggest contributor to the balance. Fisher & Paykel conduct their own R&D and hold over a thousand patents with another 1,200 pending. They manufacture in New Zealand and Mexico and have a multi-channel distribution model.
Auckland, NTL, 2013, New Zealand